In the context of colorectal cancer, splenic and ovarian metastases are rare outside of widely disseminated disease. Growing evidence suggests that 'oligometastatic' or limited metastatic disease can be treated surgically with good oncological outcomes. Splenic and ovarian metastases are not well represented in studies of oligometastatic colorectal cancer, resulting in uncertainty in the best management for these patients. We present the case of a 78-year-old woman diagnosed with oligometastatic colorectal cancer to bilateral ovaries and spleen, 5 years after resection of a primary colon cancer. The patient was treated with a bilateral salpingo-oopherectomy and subsequent open splenectomy. We discuss the role of surgery and peri-operative chemotherapy in the management of oligometastatic colorectal cancer involving atypical sites.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC11026058 | PMC |
| http://dx.doi.org/10.1093/jscr/rjae241 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Results of a single arm phase II clinical trial: online-adaptive stereotactic body radiotherapy of abdominal-pelvic oligometastases.
Int J Radiat Oncol Biol Phys
December 2024
Department of Radiotherapy, Erasmus MC Cancer Institute, Rotterdam, The Netherlands.
Purpose: This study reports on the clinical outcomes of the single arm phase-II STEAL trial investigating online adaptive stereotactic body radiotherapy (SBRT) for abdominal-pelvic lymph node (A-P LN) oligometastases.
Methods: Patients with oligometastatic A-P LN were enrolled and treated to a total dose of 45 Gy in five fractions on the CyberKnife. For each patient, a library of three plans was created using a pre-treatment diagnostic CT scan and the treatment planning CT scan.
Disparities in Palliative Treatment Utilization in Metastatic Colorectal Cancer Patients.
Ann Surg Oncol
November 2024
Department of Surgery, University of California Irvine, Orange, CA, USA.
Article Synopsis
- Patients with metastatic colorectal cancer (mCRC) often need palliative care to improve their quality of life, but there are disparities based on sociodemographic factors that affect who receives this care.
- A study analyzing data from 2016 to 2020 found that only 18% of mCRC patients received palliative treatment, with older patients and those with certain types of metastases less likely to access it.
- The research highlights that patients with multiple metastatic sites are more likely to receive palliative treatment compared to those with limited sites, and there is a significant influence of age and education level on treatment utilization.
Pushing boundaries: simultaneous minimal-invasive resection of complex colorectal liver metastases and its primary tumor.
Surg Endosc
January 2025
Department of Surgery, Campus Virchow Klinikum, Campus Charité Mitte, Charité - Universitätsmedizin Berlin, Augustenburger Platz 1, 13353, Berlin, Germany.
Introduction: Synchronous liver metastases occur in approximately 15-20% of patients with colorectal cancer. Optimal oncological treatment of oligometastatic disease combines surgical resection and systemic therapy. Open simultaneous resection of the primary and liver metastases is well described, but there is not much evidence for the increasing use of the minimally invasive approach.
View Article and Find Full Text PDFOligo-Metastatic Ductal Breast Carcinoma Presenting as a Subcutaneous Nape Nodule: A Case Report.
Cureus
October 2024
Department of Surgical Oncology, Kuwait Cancer Control Center (KCCC), Kuwait, KWT.
Breast cancer (BC) in females is the most diagnosed cancer and the leading cause of cancer death in women worldwide, followed by lung, colorectal, and cervical cancers. For oligo-metastatic (OM) cancers, the best definition is a maximum of five metastatic foci, not necessarily located in the same organ or anatomic region, all potentially treatable by ablative local treatment: either surgical resection or radiation when accessible. Oligo-metastatic breast cancer (OM-BC) is currently arising as an emerging entity with more focused research needed to upgrade the guidelines for best management.
View Article and Find Full Text PDFCarcinoma colon masquerading as bleeding per vagina.
Indian J Cancer
October 2024
Department of Radiation Oncology, Regional Cancer Centre, Trivandrum, Kerala, India.
Isolated vaginal metastasis from colorectal cancer is a rare entity with very few reports in the literature. Here we report a patient who presented with bleeding per vagina from a vaginal mucosal lesion. Biopsy of the vaginal lesion indicated a metastatic adenocarcinoma from a colorectal primary.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!